Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Douglas Laidlaw"'
Autor:
Pramukh Arun Kumar, Boskey Patel, Mahati Dasari, Sumukh Arun Kumar, Neeta Shah, Douglas Laidlaw
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-6 (2023)
Abstract Background Infective endocarditis can progress to an intracardiac abscess in 20% to 30% of cases, with interventricular septal abscess (IVSA) being one of the rare complications usually presenting with sepsis. We present a case of IVSA prese
Externí odkaz:
https://doaj.org/article/57c76f49e49543d799b556c327749154
Autor:
Ibragim, Al-Seykal, Abhishek, Bose, Parag A, Chevli, Zeba, Hashmath, Nitish, Sharma, Ajay K, Mishra, Douglas, Laidlaw
Publikováno v:
World Journal of Cardiology. 14:537-545
Cryoballoon ablation (CBA) is recommended for patients with paroxysmal atrial fibrillation (AF) refractory to antiarrhythmic drugs. However, only 80% of patients benefit from initial CBA. There is growing evidence that pretreatment with angiotensin-c
Autor:
Parag A Chevli, Ghasan Ahmad, Gregory Berberian, Douglas Laidlaw, Abhishek Bose, Ajay Kumar Mishra, Zeba Hashmath, Jerzy Januszkiewicz
Publikováno v:
Journal of Interventional Cardiac Electrophysiology. 62:409-417
Pulmonary vein (PV) isolation using cryoballoon ablation (CBA) is a common therapy for patients with drug-refractory paroxysmal atrial fibrillation (PAF). However, initial CBA is successful in only 70–80% of patients. The role of an atypical left c
Autor:
Qiying Dai, Pengyang Li, Abhishek Bose, Peng Cai, Ling Jin, Su Pan, Richard A.F. Dixon, Douglas Laidlaw, Qi Liu
Publikováno v:
The American journal of the medical sciences.
The effects of atrial fibrillation (AF) and its burden on in-hospital mortality in patients with Takotsubo cardiomyopathy (TCM) are unclear. Here, we examined the effect of AF and paroxysmal AF on in-hospital outcomes in patients with TCM.We used ICD
Publikováno v:
Circulation. 142
Introduction: Takotsubo cardiomyopathy (TC), characterized by transient left ventricular dysfunction, is known to be precipitated by sudden physical or emotional stress. Atrial fibrillation (AF) is a common arrhythmia and its presence increases morta
Autor:
Jerzy Januszkiewicz, Parag A Chevli, Ghasan Ahmad, Zeba Hashmath, Gregory Berberian, Douglas Laidlaw, Abhishek Bose, Ajay Kumar Mishra, Qiying Dai
Publikováno v:
Circulation. 142
Introduction: Cryoballoon ablation (CBA) is recommended for patients with paroxysmal atrial fibrillation (AF) refractory to anti-arrhythmic drugs. However, only 70% of patients benefit from an initial CBA. Obesity is a known risk factor for developme
Autor:
Hafiz U. Ghafoor, Gregory Berberian, Parag Anilkumar Chevli, Abhishek Bose, Zeba Hashmath, Douglas Laidlaw, Ajay Kumar Mishra, Jerzy Januszkiewicz, Ghasan Ahmad
Publikováno v:
Journal of the American College of Cardiology. 75:456
In spite of acute pulmonary vein isolation in cryoballoon ablation (CBA) for paroxysmal atrial fibrillation (AF), about one third of patients have recurrence of atrial arrhythmias (AA). Presence of obstructive sleep apnea (OSA) is a known risk factor
Autor:
Gregory Berberian, Abhishek Bose, Ghasan Ahmad, Zeba Hashmath, Douglas Laidlaw, Jerzy Januszkiewicz, Parag Anilkumar Chevli, Ajay Kumar Mishra
Publikováno v:
Journal of the American College of Cardiology. 75:457
Cryoballoon ablation (CBA) is an effective therapy for patients with paroxysmal atrial fibrillation (AF) refractory to drug therapy. However, initial CBA is successful in only 70% of patients. Over time, greater AF burden leads to irreversible electr
Autor:
Wojciech Zareba, Kathleen Gear, Scott McNitt, Frank I. Marcus, N.A. Mark Estes, Douglas Laidlaw, Mark S. Link, Bronislava Polonsky
Publikováno v:
Journal of the American College of Cardiology. 64(2):119-125
Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with sudden cardiac death. However, the selection of patients for implanted cardioverter-defibrillators (ICDs), as well as programming of the ICD, is unclear. Objectives
Publikováno v:
Current Cardiology Reviews. 3:23-33
Ventricular arrhythmias are common in the setting of acute myocardial infarction (AMI). In todays era of reperfusion therapy, anti-arrhythmic medications, and Implantable Cardioverter Defibrillators (ICDs), an understanding of these arrhythmias and t